Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

I think it is logical to assume a reasonably large premium for best in class insulin product. Based on my layman's knowledge of diabetes, any significant improvement in mimicking the body's natural insulin response must automatically go to the head of the line as the preferred therapy. Failure to do so unjustifiably subjects patients to the vast array of deleterious effects caused by the disease.
Good luck!
-Fritz